Global Anal and Colorectal Cancer Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 3661

Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in anus in case of anal cancer.
Rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has been the major factor driving the market growth.
In 2018, the global Anal and Colorectal Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Anal and Colorectal Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anal and Colorectal Cancer development in United States, Europe and China.

The key players covered in this study
Abbott Diagnostics
Advaxis
Alere
Amgen
Atara Biotherapeutics
Bayer
Metabiomics
Beckman Coulter
BeiGene
Boehringer Ingelheim
Clinical Genomics
EDP Biotech
Eli Lilly
Epigenomics
Exact Sciences
Genomictree
Immunovaccine
ISA Pharmaceuticals
Merck

Market segment by Type, the product can be split into
Surgery
Radiation therapy
Colorectal cancer chemotherapy
Targeted therapy
Immunotherapy

Market segment by Application, split into
Hospitals
Ambulatory surgery centers
Cancer research centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anal and Colorectal Cancer status, future forecast, growth opportunity, key market and key players.
To present the Anal and Colorectal Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anal and Colorectal Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anal and Colorectal Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Radiation therapy
1.4.4 Colorectal cancer chemotherapy
1.4.5 Targeted therapy
1.4.6 Immunotherapy
1.5 Market by Application
1.5.1 Global Anal and Colorectal Cancer Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory surgery centers
1.5.4 Cancer research centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Anal and Colorectal Cancer Market Size
2.2 Anal and Colorectal Cancer Growth Trends by Regions
2.2.1 Anal and Colorectal Cancer Market Size by Regions (2014-2025)
2.2.2 Anal and Colorectal Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Anal and Colorectal Cancer Market Size by Manufacturers
3.1.1 Global Anal and Colorectal Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Anal and Colorectal Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anal and Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Anal and Colorectal Cancer Key Players Head office and Area Served
3.3 Key Players Anal and Colorectal Cancer Product/Solution/Service
3.4 Date of Enter into Anal and Colorectal Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Anal and Colorectal Cancer Market Size by Type (2014-2019)
4.2 Global Anal and Colorectal Cancer Market Size by Application (2014-2019)

5 United States
5.1 United States Anal and Colorectal Cancer Market Size (2014-2019)
5.2 Anal and Colorectal Cancer Key Players in United States
5.3 United States Anal and Colorectal Cancer Market Size by Type
5.4 United States Anal and Colorectal Cancer Market Size by Application

6 Europe
6.1 Europe Anal and Colorectal Cancer Market Size (2014-2019)
6.2 Anal and Colorectal Cancer Key Players in Europe
6.3 Europe Anal and Colorectal Cancer Market Size by Type
6.4 Europe Anal and Colorectal Cancer Market Size by Application

7 China
7.1 China Anal and Colorectal Cancer Market Size (2014-2019)
7.2 Anal and Colorectal Cancer Key Players in China
7.3 China Anal and Colorectal Cancer Market Size by Type
7.4 China Anal and Colorectal Cancer Market Size by Application

8 Japan
8.1 Japan Anal and Colorectal Cancer Market Size (2014-2019)
8.2 Anal and Colorectal Cancer Key Players in Japan
8.3 Japan Anal and Colorectal Cancer Market Size by Type
8.4 Japan Anal and Colorectal Cancer Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Anal and Colorectal Cancer Market Size (2014-2019)
9.2 Anal and Colorectal Cancer Key Players in Southeast Asia
9.3 Southeast Asia Anal and Colorectal Cancer Market Size by Type
9.4 Southeast Asia Anal and Colorectal Cancer Market Size by Application

10 India
10.1 India Anal and Colorectal Cancer Market Size (2014-2019)
10.2 Anal and Colorectal Cancer Key Players in India
10.3 India Anal and Colorectal Cancer Market Size by Type
10.4 India Anal and Colorectal Cancer Market Size by Application

11 Central & South America
11.1 Central & South America Anal and Colorectal Cancer Market Size (2014-2019)
11.2 Anal and Colorectal Cancer Key Players in Central & South America
11.3 Central & South America Anal and Colorectal Cancer Market Size by Type
11.4 Central & South America Anal and Colorectal Cancer Market Size by Application

12 International Players Profiles
12.1 Abbott Diagnostics
12.1.1 Abbott Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anal and Colorectal Cancer Introduction
12.1.4 Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.1.5 Abbott Diagnostics Recent Development
12.2 Advaxis
12.2.1 Advaxis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anal and Colorectal Cancer Introduction
12.2.4 Advaxis Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.2.5 Advaxis Recent Development
12.3 Alere
12.3.1 Alere Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anal and Colorectal Cancer Introduction
12.3.4 Alere Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.3.5 Alere Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anal and Colorectal Cancer Introduction
12.4.4 Amgen Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 Atara Biotherapeutics
12.5.1 Atara Biotherapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anal and Colorectal Cancer Introduction
12.5.4 Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.5.5 Atara Biotherapeutics Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anal and Colorectal Cancer Introduction
12.6.4 Bayer Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Metabiomics
12.7.1 Metabiomics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anal and Colorectal Cancer Introduction
12.7.4 Metabiomics Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.7.5 Metabiomics Recent Development
12.8 Beckman Coulter
12.8.1 Beckman Coulter Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anal and Colorectal Cancer Introduction
12.8.4 Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.8.5 Beckman Coulter Recent Development
12.9 BeiGene
12.9.1 BeiGene Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anal and Colorectal Cancer Introduction
12.9.4 BeiGene Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.9.5 BeiGene Recent Development
12.10 Boehringer Ingelheim
12.10.1 Boehringer Ingelheim Company Details
12.10.2 Company Description and Business Overview
12.10.3 Anal and Colorectal Cancer Introduction
12.10.4 Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2014-2019)
12.10.5 Boehringer Ingelheim Recent Development
12.11 Clinical Genomics
12.12 EDP Biotech
12.13 Eli Lilly
12.14 Epigenomics
12.15 Exact Sciences
12.16 Genomictree
12.17 Immunovaccine
12.18 ISA Pharmaceuticals
12.19 Merck

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details